Updating results

225 results for urinary tract infections

Sort: Relevance | Date

Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA355)

Evidence-based recommendations on edoxaban (Lixiana) for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (AF)

Technology appraisal guidance Published September 2015

Cost-saving guidance

NICE guidance that could generate cost savings.

Published April 2019 Last updated April 2019

Dapagliflozin with insulin for treating type 1 diabetes (TA597)

Evidence-based recommendations on dapagliflozin (Forxiga) with insulin for type 1 diabetes not controlled by insulin therapy alone in adults with a BMI of at

Technology appraisal guidance Published August 2019

The NGAL Test for early diagnosis of acute kidney injury (MIB3)

Advice on the use of the NGAL Test for early diagnosis of acute kidney injury (AKI) to aid local decision-making

Medtech innovation briefing Published February 2014

The TURis system for transurethral resection of the prostate (MTG23)

Evidence-based recommendations on the transurethral resection in saline system (TURis) for resection of the prostate

Medical technologies guidance Published February 2015

Secca System for faecal incontinence (MIB66)

Advice on the use of the Secca system for treating faecal incontinence to aid local decision-making

Medtech innovation briefing Published May 2016

Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition (CG32)

This guideline covers identifying and caring for adults who are malnourished or at risk of malnutrition in hospital or in their own home or a care home. It offers advice on how oral, enteral tube feeding and parenteral nutrition support should be started, administered and stopped. It aims to support healthcare professionals identify malnourished people and help them to choose the most appropriate form of support.

Clinical guideline Published February 2006 Last updated August 2017

Cerebral palsy in adults (NG119)

This guideline covers care and support for adults with cerebral palsy. It aims to improve health and wellbeing, promote access to services and support participation and independent living.

NICE guideline Published January 2019

Sexually transmitted infections and under-18 conceptions: prevention (PH3)

This guideline covers one-to-one interventions to prevent sexually transmitted infections (STIs) and under-18 conceptions. The aim is to reduce the transmission of chlamydia and other STIs, including HIV, and reduce the rate of pregnancies among women aged under 18.

Public health guideline Published February 2007

Prostate cancer: diagnosis and management (NG131)

This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer.

NICE guideline Published May 2019

Cystic fibrosis: diagnosis and management (NG78)

This guideline covers diagnosing and managing cystic fibrosis. It specifies how to monitor the condition and manage the symptoms to improve quality of life. There are also detailed recommendations on treating the most common infections in people with cystic fibrosis.

NICE guideline Published October 2017

Scleroderma: oral mycophenolate (ESUOM32)

Summary of the evidence on oral mycophenolate for systemic sclerosis (scleroderma) to inform local NHS planning and decision-making

Evidence summary Published July 2014

Alemtuzumab for treating relapsing‑remitting multiple sclerosis (TA312)

Evidence-based recommendations on alemtuzumab (Lemtrada) for treating active relapsing–remitting multiple sclerosis (MS)

Technology appraisal guidance Published May 2014

Diabetes in children and young people

Everything NICE has said on diagnosing and managing type 1 and 2 diabetes in children and young people in an interactive flowchart

NICE Pathway Published May 2011 Last updated June 2019

Tests for rapidly identifying bloodstream bacteria and fungi (LightCycler SeptiFast Test MGRADE, SepsiTest and IRIDICA BAC BSI assay) (DG20)

Evidence-based recommendations on the LightCycler SeptiFast Test MGRADE, SepsiTest and IRIDICA BAC BSI assay for identifying bloodstream bacteria and fungi

Diagnostics guidance Published February 2016

MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes (MIB51)

Advice on the MiniMed 640G system with SmartGuard for managing blood glucose levels in type 1 diabetes to aid local decision-making

Medtech innovation briefing Published February 2016

Delirium

Everything NICE has said on preventing and managing delirium in adults presenting to hospital or in long-term care in an interactive flowchart

NICE Pathway Published September 2012 Last updated March 2019

Faecal incontinence in adults: management (CG49)

This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis.

Clinical guideline Published June 2007

Preventing falls in older people

Everything NICE has said on assessing and preventing falls in older people in the community and in hospital, in an interactive flowchart

NICE Pathway Published June 2013 Last updated September 2017

Fulvestrant for the treatment of locally advanced or metastatic breast cancer (TA239)

Evidence-based recommendations on fulvestrant (Faslodex) for treating locally advanced or metastatic breast cancer

Technology appraisal guidance Published December 2011

Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) (IPG192)

Evidence-based recommendations on therapeutic amnioinfusion for treating oligohydramnios (lack of amniotic fluid ) during pregnancy (excluding labour)

Interventional procedures guidance Published November 2006

Gouty arthritis: canakinumab (ESNM23)

Summary of the evidence on canakinumab for treating gouty arthritis (gout) to inform local NHS planning and decision-making

Evidence summary Published July 2013

Irreversible electroporation for treating pancreatic cancer (IPG579)

Evidence-based recommendations on irreversible electroporation (IRE) for treating pancreatic cancer

Interventional procedures guidance Published May 2017

Medical Technologies Advisory Committee members

genetic basis of cancer and inflammatory diseases of the gastrointestinal tract. As well as basic cell and molecular biology, he has...

Published November 2019 Last updated November 2019

Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure (IPG602)

Evidence-based recommendations on artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure

Interventional procedures guidance Published December 2017

Urethrotech UCD for difficult or failed catheterisation (MIB116)

Advice on the use of Urethrotech urethral catheterisation device (UCD) for difficult or failed catheterisations in men to aid local decision-making

Medtech innovation briefing Published August 2017

Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen (TA259)

Evidence-based recommendations on abiraterone (Zytiga) for castration-resistant metastatic prostate cancer in adults previously treated with docetaxel

Technology appraisal guidance Published June 2012 Last updated July 2016

Physical health of people in prison (NG57)

This guideline covers assessing, diagnosing and managing physical health problems of people in prison. It aims to improve health and wellbeing in the prison population by promoting more coordinated care and more effective approaches to prescribing, dispensing and supervising medicines.

NICE guideline Published November 2016

Faecal incontinence

Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart

NICE Pathway Published February 2013 Last updated June 2019

Integrated multiplex PCR tests for identifying gastrointestinal pathogens in people with suspected gastroenteritis (xTAG Gastrointestinal Pathogen Panel, FilmArray GI Panel and Faecal Pathogens B assay) (DG26)

Evidence-based recommendations on integrated multiplex polymerase chain tests for identifying gastrointestinal pathogens in suspected gastroenteritis

Diagnostics guidance Published January 2017

Chronic obstructive pulmonary disease: umeclidinium inhaler (Incruse) (ESNM52)

Summary of the evidence on umeclidinium inhaler (Incruse) for chronic obstructive pulmonary disease to inform local NHS planning and decision-making

Evidence summary Published January 2015

Mental wellbeing and independence in older people

Everything NICE has said on promoting mental wellbeing and independence in older people over 65 in an interactive flowchart

NICE Pathway Published November 2012 Last updated December 2016

Denosumab for the prevention of osteoporotic fractures in postmenopausal women (TA204)

Evidence-based recommendations on denosumab (Prolia) for preventing osteoporotic fragility fractures in postmenopausal women

Technology appraisal guidance Published October 2010

Postnatal care up to 8 weeks after birth (CG37)

This guideline covers the routine postnatal care women and their babies should receive for 6–8 weeks after the birth. It includes advice given on breastfeeding, and the management of common and serious health problems in women and their babies after the birth.

Clinical guideline Published July 2006 Last updated February 2015

Asthma: fluticasone furoate/vilanterol (Relvar Ellipta) combination inhaler (ESNM34)

Summary of the evidence on the fluticasone furoate/vilanterol (Relvar Ellipta) combination inhaler for asthma to inform local NHS planning and decision-making

Evidence summary Published March 2014

Hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus: telavancin (ESNM44)

Summary of the evidence on telavancin (Vibativ) for hospital-acquired pneumonia caused by MRSA to inform local NHS planning and decision-making

Evidence summary Published July 2014

Social anxiety disorder

Everything NICE has said on recognising, assessing and treating social anxiety disorder in children, young people and adults in an interactive flowchart

NICE Pathway Published May 2013 Last updated December 2018

Mental wellbeing of older people in care homes (QS50)

This quality standard covers the mental wellbeing of older people (aged 65 and over) receiving care in care homes (including residential and nursing accommodation, day care and respite care). It focuses on support for people to improve their mental wellbeing so that they can stay as well and independent as possible. It describes high-quality care in priority areas for improvement.

Quality standard Published December 2013

Dapagliflozin in triple therapy for treating type 2 diabetes (TA418)

Evidence-based recommendations on dapagliflozin (Forxiga) given with 2 other drugs for treating type 2 diabetes in adults

Technology appraisal guidance Published November 2016

Multiple sclerosis (QS108)

This quality standard covers diagnosing and managing multiple sclerosis (MS) in adults. It includes care, support and review for people with MS. It describes high-quality care in priority areas for improvement.

Quality standard Published January 2016

Dementia

Everything NICE has said on assessment, management and support for people living with dementia and Alzheimer's disease and their carers in an interactive flowchart

NICE Pathway Published May 2011 Last updated June 2019

Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy (TA307)

Evidence-based recommendations on aflibercept (Zaltrap) with FOLFIRI for metastatic colorectal cancer that has progressed after oxaliplatin

Technology appraisal guidance Published March 2014

Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis (TA276)

Evidence-based recommendations on colistimethate sodium and tobramycin dry powders for inhalation for pseudomonas lung infection in cystic fibrosis

Technology appraisal guidance Published March 2013

Bladder management strategies:- What are the long-term risks and effects on quality of life of different bladder management strategies for lower urinary tract dysfunction in people with neurological disease?

quality of life of different bladder management strategies for lower urinary tract dysfunction in people with neurological...

Research recommendation Published June 2015

Type 2 diabetes: alogliptin (ESNM20)

Summary of the evidence on alogliptin (a dipeptidyl peptidase-4 [DPP-4] inhibitor) for type 2 diabetes to inform local NHS planning and decision-making

Evidence summary Published May 2013 Last updated October 2014

Health of people in the criminal justice system

Everything NICE has said on managing the physical and mental health of people in prison, and the mental health of people in the criminal justice system

NICE Pathway Published November 2016 Last updated August 2019

Being monitored and out of remit procedures

Non-ablative radiofrequency treatment of bladder neck and urethra for stress urinary incontinence Monitor - no CE marked devices 1476 /...

Published August 2019 Last updated August 2019

Xpert GBS test for the intrapartum detection of group B streptococcus (MIB28)

Advice on the use of the Xpert GBS test for the intrapartum detection of group B streptococcus (GBS) colonisation in pregnant women...

Medtech innovation briefing Published April 2015

Chronic kidney disease

Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart

NICE Pathway Published May 2011 Last updated September 2019